|
⚲
|
| Keyboard |
| Fairmount Healthcare Co-Invest V LP
✚
|
|
|---|---|
| CIK # | 0002091559 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002091559] | |
| 4 | [0002091559] | |
| D | [0002091559] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kiselak Tomas | |
| Fairmount Funds Management LLC | |
| Damora Therapeutics Inc | |
| Harwin Peter Evan | |
| Fairmount Healthcare Fund II LP | |
| Fairmount Healthcare Co-Invest V LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
|
2026-03-23 | Grant | 37,313 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2026-02-09 | Option exercise | 5,809,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Common Stock
|
2026-02-09 | Option exercise | 2,904,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 5,809 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
|
2026-02-09 | Option exercise | 2,904 | $0.00 |